Pepgen Is A Clinical Stage Biotechnology Company Based In Bostonmassachusettsthe Company Focuses On Developing Innovative Oligonucleotide Therapies Aimed At Treating Severe Neuromuscular And Neurological Diseasesutilizing Its Proprietary Enhanced Delivery Oligonucleotideedoplatformpepgen Seeks To Improve The Delivery And Effectiveness Of Therapies By Achieving Deep Tissue Penetration And High Uptake In Key Muscle Tissues Pepgen Is Dedicated To Creating Transformativedisease Modifying Treatments That Can Potentially Haltslowor Reverse The Progression Of Conditions Such As Duchenne Muscular Dystrophydmdand Myotonic Dystrophy Type 1Dm1 The Team Comprises Experts From Various Fieldsincluding Scientistsphysiciansand Industry Leadersall Committed To Advancing Clinical Trials And Improving The Lives Of Individuals Affected By These Diseases
No conferences found for this company.
| Company Name | Pepgen Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
